Search by Drug Name or NDC
NDC 00642-7466-05 Nuvessa 65 mg/5g Details
Nuvessa 65 mg/5g
Nuvessa is a TOPICAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Exeltis USA, Inc.. The primary component is METRONIDAZOLE.
MedlinePlus Drug Summary
Metronidazole is used to treat vaginal infections such as bacterial vaginosis (an infection caused from too much of certain bacteria in the vagina). Metronidazole is in a class of medications called nitroimidazole antimicrobials. It works by stopping the growth of bacteria.
Related Packages: 00642-7466-05Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Metronidazole Vaginal
Product Information
| NDC | 00642-7466 |
|---|---|
| Product ID | 0642-7466_09d13114-f228-f0bc-e063-6394a90a84f5 |
| Associated GPIs | 55100035004030 |
| GCN Sequence Number | 072182 |
| GCN Sequence Number Description | metronidazole GEL W/APPL 1.3 % VAGINAL |
| HIC3 | Q4W |
| HIC3 Description | VAGINAL ANTIBIOTICS |
| GCN | 36303 |
| HICL Sequence Number | 004157 |
| HICL Sequence Number Description | METRONIDAZOLE |
| Brand/Generic | Brand |
| Proprietary Name | Nuvessa |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | metronidazole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | GEL |
| Route | TOPICAL |
| Active Ingredient Strength | 65 |
| Active Ingredient Units | mg/5g |
| Substance Name | METRONIDAZOLE |
| Labeler Name | Exeltis USA, Inc. |
| Pharmaceutical Class | Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA205223 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00642-7466-05 (00642746605)
| NDC Package Code | 0642-7466-05 |
|---|---|
| Billing NDC | 00642746605 |
| Package | 1 APPLICATOR in 1 CARTON (0642-7466-05) / 5 g in 1 APPLICATOR |
| Marketing Start Date | 2018-03-10 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 39.0613 |
| Pricing Unit | GM |
| Effective Date | 2024-01-15 |
| NDC Description | NUVESSA VAGINAL 1.3% GEL |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis